Dr. Tella is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
Mayo Clinic, 200 1st street SW
Rochester, MN 55901Phone+1 402-280-4180- Is this information wrong?
Summary
- Dr. Sri Harsha Tella is an oncologist in Rochester, MN and is affiliated with Mayo Clinic Hospital - Rochester. He received his medical degree from Creighton University School of Medicine and has been in practice 6 years. He specializes in endocrine cancer and gastrointestinal cancer. He has more than 80 publications and over 2500 citings.
Education & Training
National Institutes of Health Clinical CenterFellowship, Endocrinology, Diabetes, and Metabolism, 2015 - 2017
Creighton University School of Medicine (Omaha)Residency, Internal Medicine, 2012 - 2015- Creighton University School of MedicineClass of 2011
Certifications & Licensure
ID State Medical License 2023 - 2024
MN State Medical License 2020 - 2023
SC State Medical License 2017 - 2021
DC State Medical License 2015 - 2018- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Raisz-Drezner Awardee ASBMR, 2018
Publications & Presentations
PubMed
- 1 citationsProjected Incidence of Hepatobiliary Cancers and Trends Based on Age, Race, and Gender in the United States.Wieczorek, M., Hodge, D., Elrod, J., Rosenberg, P., Storandt, M., Tella, S., Jin, Z., Mahipal, A.> ;Cancers. 2024 Feb 6
- 2 citationsRole of innate immunological/inflammatory pathways in myelodysplastic syndromes and AML: a narrative review.Charan Thej Reddy Vegivinti, Praneeth Reddy Keesari, Sindhusha Veeraballi, Catarina Maria Pina Martins Maia, Ansh Krishnachandra Mehta, Rohit Reddy Lavu, Rahul Kumar T...> ;Experimental Hematology & Oncology. 2023 Jul 8
- Phase II Trial of Trifluridine/Tipiracil Plus Irinotecan in Patients with Advanced, Refractory Biliary Tract Carcinoma.Sri Harsha Tella, Nathan Foster, Shi Qian, Tran Nguyen, Mitesh J Borad, Robert R McWilliams, Steven R Alberts, Wen Wee Ma, Sakti Chakrabarti, Briant Fruth, Jaclynn Wes...> ;The Oncologist. 2023 Oct 3
- Join now to see all
Lectures
- Disparities in the receipt of palliative care (PC) in metastatic renal cell carcinoma (mRCC).2019 ASCO Annual Meeting - 6/1/2019
- Novel staging system using carbohydrate antigen (CA) 19-9 in extrahepatic cholangiocarcinoma (ECCC) and its implications on overall survival (OS).2019 ASCO Annual Meeting - 6/1/2019
Hospital Affiliations
Mayo Clinic Hospital - RochesterRochester, Minnesota
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
